Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of tigecycline in patients receiving continuous renal replacement therapy
2012-005617-39Phase 4Completed
- Sponsor
- University Hospital Tübingen
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tigecycline in bacterial disease (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: AUC of tigecycline. Started Dec 2013; status: completed.
02
Drugs
tigecycline
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2012-005617-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005617-39.